For important information regarding GRC’s vaccination policy and on-site COVID-19 protocols, please click here.

GRC Connects: Innovation by Biomaterials


March 8, 2021
1:00 PM - 3:00 PM EST


Featuring talks by

Dr. Kristi AnsethUniversity of Colorado at Boulder 

Dr. Chad MirkinNorthwestern University

Moderated by 

Dr. Shana Kelley, University of Toronto


Event Description

The contributions made by women over the last century continue to impact the sciences and the GRC organization today. Join us on International Women’s Day, as we highlight the important work of women in our communities, and scientific talks on the subject of “Innovation by Biomaterials” at this GRC Connects event.  

Drs. Kristi Anseth and Chad A. Mirkin, both longstanding and valued members of the GRC community and GRC governance, will be featured as keynote speakers. In addition to their scientific talks, Dr. Anseth and Dr. Mirkin will discuss the contributions women have made to their research at this free event, open to all members of the scientific community and scientists of all career-stages.  Dr. Shana Kelley, University of Toronto, will moderate the discussion.  

Dr. Anseth, Professor of Chemistry and Biological Engineering at the University of Colorado at Boulder, recently awarded the L’Oreal-UNESCO for Women in Science Award in Life Sciences, will present a scientific talk titled “Advances in Precision Biomaterials to Direct Cell Organization and Tissue Regeneration.”

Dr. Mirkin, Professor of Chemistry and Director of the International Institute for Nanotechnology at Northwestern University, recently awarded the Kabiller Prize in Nanoscience and Nanomedicine, will present a scientific talk titled “Nanomedicine: Why Scale and Chemical Structure Make a Difference.”

Please join us for an engaging and informative presentation followed by a Q&A period with these influential scientists. We look forward to seeing you at the frontiers of science!

 

 About the Speakers

Kristi Anseth is a Professor of Chemical and Biological Engineering and Associate Faculty Director of the BioFrontiers Institute at the University of Colorado at Boulder. She currently holds the Tisone Professorship and is a Distinguished Professor. Dr. Anseth came to CU-Boulder after earning her B.S. degree from Purdue University, her Ph.D. degree from the University of Colorado, and completing post-doctoral research at MIT as an NIH fellow. Her research interests lie at the interface between biology and engineering where she designs new biomaterials for applications in drug delivery and regenerative medicine. Dr. Anseth’s research group has published over 350 peer-reviewed manuscripts, and she has trained more than 110 graduate students and postdoctoral associates. She is an elected member of the National Academy of Engineering (2009), the National Academy of Medicine (2009), the National Academy of Sciences (2013), the National Academy of Inventors (2016) and the American Academy of Arts and Sciences (2019). Most recently, she received the L’Oreal-UNESCO for Women in Science Award in the Life Sciences (2020). Dr. Anseth has served on the Board of Directors and as President of the Materials Research Society, the Board of Governors for Acta Materialia, Inc, the NIH Advisory Council for NIBIB, and as Chair of the NAE US Frontiers of Engineering meetings. 

 

Chad A. Mirkin is the Director of the International Institute for Nanotechnology and the George B. Rathmann Prof. of Chemistry, Chemical and Biological Engineering, Biomedical Engineering, Materials Science & Engineering, and Medicine at Northwestern University. He is a chemist and a world-renowned nanoscience expert, who is known for his discovery and development of spherical nucleic acids (SNAs) and SNA-based biodetection and therapeutic schemes, Dip-Pen Nanolithography (DPN) and related cantilever-free nanopatterning methodologies, On-Wire Lithography (OWL), and Co-Axial Lithography (COAL), and contributions to supramolecular chemistry and nanoparticle synthesis. He is the author of over 790 manuscripts and over 1,200 patent applications worldwide (over 355 issued), and he is the founder of multiple companies, including AuraSense, Exicure, TERA-print, Azul 3D and Stoicheia, which are commercializing nanotechnology applications in the life sciences, biomedicine, and advanced manufacturing. Mirkin has been recognized with over 230 national and international awards, including the Kabiller Prize in Nanoscience and Nanomedicine, Dan David Prize, and NAS Sackler Prize in Convergence Research. He was a Member of the President’s Council of Advisors on Science & Technology and is one of very few scientists to be elected to all three US National Academies. He is also a Fellow of the American Academy of Arts and Sciences and the National Academy of Inventors, among others. Mirkin has served on the Editorial Advisory Boards of over 30 scholarly journals, including J. Am. Chem. Soc., ACS Nano, and Nano Letters. At present, he is an Associate Editor of J. Am. Chem. Soc. and a Proc. Natl. Aca. Sci. Editorial Board Member, and he is the founding editor of the journal Small. Mirkin holds a B.S. from Dickinson College (1986, elected into Phi Beta Kappa) and a Ph.D. from the Penn. State Univ. (1989). He was an NSF Postdoctoral Fellow at the MIT prior to becoming a professor at Northwestern Univ. in 1991.

 About the Moderator

Shana Kelley is a University Professor at the University of Toronto and a member of the Departments of Chemistry, Biochemistry, Pharmaceutical Sciences and Biomedical Engineering. Dr. Kelley received her Ph.D. from the California Institute of Technology and was a NIH postdoctoral fellow at the Scripps Research Institute. The Kelley research group works in a variety of areas spanning biophysical/bioanalytical chemistry, chemical biology and nanotechnology, and has pioneered new methods for tracking molecular and cellular analytes with unprecedented sensitivity. Dr. Kelley’s work has been recognized with a variety of distinctions, including being named one of “Canada’s Top 40 under 40”, a NSERC E.W.R. Steacie Fellow, the 2011 Steacie Prize, and the 2016 NSERC Brockhouse Prize. She has also been recognized with the ACS Inorganic Nanoscience Award, the Pittsburgh Conference Achievement Award, an Alfred P. Sloan Research Fellowship, a Camille Dreyfus Teacher-Scholar award, a NSF CAREER Award, a Dreyfus New Faculty Award, and was also named a “Top 100 Innovator” by MIT’s Technology Review. Kelley is an inventor on over 50 patents issued worldwide. She is a founder of three molecular diagnostics companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005), Xagenic Inc. (acquired by General Atomics in 2017), and Cellular Analytics. Kelley serves as a Board Director for Ontario Genomics and a Board Trustee for the Fight Against Cancer Innovation Trust (FACIT). She is an Associate Editor for ACS Sensors, and an Editorial Advisory Board Member for the Journal of the American Chemical Society and ACS Chemical Biology.

 

GRC Connects is an initiative of the Gordon Research Conferences that provides opportunities for GRC communities to connect and collaborate until we resume in-person meetings, furthering GRC's commitment to find new and creative ways to advance the frontiers of science. 

 
Resources

 

Event Recording

 

 

GRC's Celebration of International Women's Day

 

 

 

 

 

 

 

Contact Us

Call Us:
401-783-4011

Monday - Friday 
8:30 am - 4:30 pm ET



  • Check Your Registration
    Find out about your upcoming GRC meetings.

  • GRC Venues
    Everything you need to know about our venues when planning your trip.

  • FAQs
    Instant answers to common questions.

You have no notifications